Tomas Eagan

4.3k total citations
125 papers, 3.1k citations indexed

About

Tomas Eagan is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Tomas Eagan has authored 125 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Pulmonary and Respiratory Medicine, 46 papers in Physiology and 18 papers in Molecular Biology. Recurrent topics in Tomas Eagan's work include Chronic Obstructive Pulmonary Disease (COPD) Research (74 papers), Respiratory Support and Mechanisms (32 papers) and Asthma and respiratory diseases (30 papers). Tomas Eagan is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (74 papers), Respiratory Support and Mechanisms (32 papers) and Asthma and respiratory diseases (30 papers). Tomas Eagan collaborates with scholars based in Norway, United States and Netherlands. Tomas Eagan's co-authors include Per Bakke, Amund Gulsvik, Jon A. Hardie, Geir Egil Eide, Marianne Aanerud, Thor Ueland, Pål Aukrust, Ane Johannessen, Rune Grønseth and Pieter S. Hiemstra and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Clinical Infectious Diseases.

In The Last Decade

Tomas Eagan

120 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas Eagan Norway 31 2.0k 1.1k 302 282 282 125 3.1k
Ramesh Kurukulaaratchy United Kingdom 32 1.3k 0.6× 2.1k 1.8× 230 0.8× 207 0.7× 247 0.9× 116 3.1k
Simone Accordini Italy 35 2.1k 1.0× 2.2k 1.9× 466 1.5× 110 0.4× 221 0.8× 89 3.6k
S. F. Paul Man Canada 30 3.0k 1.5× 1.3k 1.1× 296 1.0× 397 1.4× 480 1.7× 65 4.3k
Wei Xuan Australia 33 1.6k 0.8× 1.4k 1.3× 204 0.7× 881 3.1× 565 2.0× 117 4.6k
Νikolaos Koulouris Greece 38 2.9k 1.4× 1.8k 1.6× 132 0.4× 360 1.3× 315 1.1× 179 4.4k
W. M. C. van Aalderen Netherlands 33 1.6k 0.8× 1.2k 1.1× 257 0.9× 142 0.5× 649 2.3× 93 3.0k
Franca Rusconi Italy 29 1.3k 0.6× 837 0.7× 623 2.1× 175 0.6× 474 1.7× 120 3.0k
Linnéa Hedman Sweden 30 1.1k 0.5× 1.5k 1.3× 347 1.1× 96 0.3× 176 0.6× 133 2.4k
M. Diane Lougheed Canada 26 1.7k 0.8× 1.3k 1.2× 233 0.8× 104 0.4× 204 0.7× 110 2.7k
J. C. de Jongste Netherlands 39 2.3k 1.1× 2.5k 2.2× 603 2.0× 264 0.9× 390 1.4× 102 4.5k

Countries citing papers authored by Tomas Eagan

Since Specialization
Citations

This map shows the geographic impact of Tomas Eagan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas Eagan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas Eagan more than expected).

Fields of papers citing papers by Tomas Eagan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas Eagan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas Eagan. The network helps show where Tomas Eagan may publish in the future.

Co-authorship network of co-authors of Tomas Eagan

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas Eagan. A scholar is included among the top collaborators of Tomas Eagan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas Eagan. Tomas Eagan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eagan, Tomas, et al.. (2025). Gut microbiota in chronic obstructive pulmonary disease varies by CT-verified emphysema status. European Clinical Respiratory Journal. 12(1). 2470499–2470499. 1 indexed citations
2.
Husebø, Gunnar Reksten, Rune Nielsen, Andreu Paytuví-Gallart, et al.. (2025). Whole genome sequencing of the pulmonary microbiome in interstitial lung disease subtypes. Respiratory Research. 26(1). 324–324.
3.
Tangvik, Randi J., et al.. (2024). Malnutrition as a prognostic factor for 2‐year mortality in hospitalized patients in Norway: A matched cohort study. Journal of Parenteral and Enteral Nutrition. 48(3). 308–317. 3 indexed citations
4.
Eagan, Tomas, et al.. (2024). Pleural Infection: Contemporary Microbiology Completing the Picture. Clinical Infectious Diseases. 79(6). 1533–1534. 1 indexed citations
5.
Eagan, Tomas, Øystein Fløtten, Kjersti Wik Larssen, et al.. (2023). Pleural Empyema Caused by Streptococcus intermedius and Fusobacterium nucleatum: A Distinct Entity of Pleural Infections. Clinical Infectious Diseases. 77(10). 1361–1371. 12 indexed citations
6.
Carbo, Ellen C., Igor A. Sidorov, Nikolaos Pappas, et al.. (2022). Performance of Five Metagenomic Classifiers for Virus Pathogen Detection Using Respiratory Samples from a Clinical Cohort. Pathogens. 11(3). 340–340. 6 indexed citations
7.
Bjorvatn, Bjørn, et al.. (2022). Clinical information predicting severe obstructive sleep apnea: A cross-sectional study of patients waiting for sleep diagnostics. Respiratory Medicine. 197. 106860–106860. 9 indexed citations
8.
Conrad, Douglas, Barbara Bailey, Jon A. Hardie, et al.. (2017). Median regression spline modeling of longitudinal FEV1 measurements in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) patients. PLoS ONE. 12(12). e0190061–e0190061. 11 indexed citations
9.
Eagan, Tomas, Robert L. Jensen, Per Bakke, et al.. (2014). Predictors for PaO2and Hypoxemic Respiratory Failure in COPD–A Three-Year Follow-up. COPD Journal of Chronic Obstructive Pulmonary Disease. 11(5). 531–538. 10 indexed citations
10.
Husebø, Gunnar Reksten, Per Bakke, Jon A. Hardie, et al.. (2014). Macrophage migration inhibitory factor (MIF), a biomarker in COPD?. European Respiratory Journal. 44(Suppl 58). P1484–P1484. 1 indexed citations
11.
Haaland, Ingvild, et al.. (2014). Interleukin-18 levels in induced sputum of stable and exacerbated COPD patients. European Respiratory Journal. 44(Suppl 58). P848–P848. 1 indexed citations
12.
Eagan, Tomas, Per Bakke, Ingvild Haaland, et al.. (2014). Fever, hospitalization and healthcare utilization after research bronchoscopy. European Respiratory Journal. 44(Suppl 58). P702–P702. 1 indexed citations
13.
Johannessen, Ane, et al.. (2013). Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease Guidelines for Predicting Mortality and Hospitalization. American Journal of Respiratory and Critical Care Medicine. 188(1). 51–59. 67 indexed citations
14.
Johannessen, Ane, et al.. (2013). Comparison of 2011 and 2007 GOLD guidelines for predicting mortality and hospitalization. European Respiratory Journal. 42(Suppl 57). 4869–4869. 5 indexed citations
15.
Eagan, Tomas, Pål Aukrust, Thor Ueland, et al.. (2010). Body composition and plasma levels of inflammatory biomarkers in COPD. European Respiratory Journal. 36(5). 1027–1033. 30 indexed citations
16.
Johannessen, Ane, Tomas Eagan, Ernst Omenaas, Per Bakke, & Amund Gulsvik. (2010). Socioeconomic risk factors for lung function decline in a general population. European Respiratory Journal. 36(3). 480–487. 30 indexed citations
17.
Grydeland, Thomas Blix, Asger Dirksen, Harvey O. Coxson, et al.. (2009). Quantitative Computed Tomography Measures of Emphysema and Airway Wall Thickness Are Related to Respiratory Symptoms. American Journal of Respiratory and Critical Care Medicine. 181(4). 353–359. 165 indexed citations
18.
Skorge, Trude Duelien, Tomas Eagan, Geir Egil Eide, Amund Gulsvik, & Per Bakke. (2009). Occupational exposure and incidence of respiratory disorders in a general population. Scandinavian Journal of Work Environment & Health. 35(6). 454–461. 23 indexed citations
19.
Eagan, Tomas, Thor Ueland, Peter D. Wagner, et al.. (2009). Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study. European Respiratory Journal. 35(3). 540–548. 169 indexed citations
20.
Skorge, Trude Duelien, Tomas Eagan, Geir Egil Eide, Amund Gulsvik, & Per Bakke. (2005). The Adult Incidence of Asthma and Respiratory Symptoms by Passive Smoking In Utero or in Childhood. American Journal of Respiratory and Critical Care Medicine. 172(1). 61–66. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramesh Kurukulaaratchy Breakdown of academic impact, for papers by Simone Accordini Breakdown of academic impact, for papers by S. F. Paul Man Breakdown of academic impact, for papers by Wei Xuan Breakdown of academic impact, for papers by Νikolaos Koulouris Breakdown of academic impact, for papers by W. M. C. van Aalderen Breakdown of academic impact, for papers by Franca Rusconi Breakdown of academic impact, for papers by Linnéa Hedman Breakdown of academic impact, for papers by M. Diane Lougheed Breakdown of academic impact, for papers by J. C. de Jongste
Rankless by CCL
2026